Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 3 Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06943872
What this trial is testing

Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
BeOne Medicines 630
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Large-scale testing (Phase 3)Study completedNCT02032277
What this trial is testing

A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
AbbVie 634
Not applicableEnded earlyNCT02454777
What this trial is testing

High-Intensity Interval Training for Stage I-III Breast Cancer Patients

Who this might be right for
Stage IA Breast CancerStage IB Breast CancerStage IIA Breast Cancer+4 more
University of Southern California 31
Large-scale testing (Phase 3)Ended earlyNCT03970694
What this trial is testing

Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer

Who this might be right for
Colon Cancer
Sun Yat-sen University 49
Early research (Phase 1)Study completedNCT00081237
What this trial is testing

OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 15
Not applicableLooking for participantsNCT05371353
What this trial is testing

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 600
Testing effectiveness (Phase 2)Study completedNCT00054028
What this trial is testing

Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer

Who this might be right for
Recurrent Breast CancerStage IIIB Breast CancerStage IV Breast Cancer
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT01404936
What this trial is testing

Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT05912244
What this trial is testing

IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 43
Not applicableStudy completedNCT01664130
What this trial is testing

High-Dose Stereotactic Radiation for Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
Case Comprehensive Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT01827111
What this trial is testing

Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Looking for participantsNCT07226544
What this trial is testing

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

Who this might be right for
Localized Clear Cell Renal Cell CarcinomaResectable Clear Cell Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8+2 more
City of Hope Medical Center 31
Not applicableStudy completedNCT01942200
What this trial is testing

A Non Interventional Study With Oxaliplatin Onkovis (Oxaliplatin) Utilized for the Treatment of Cancer

Who this might be right for
Carcinoma
Onkovis GmbH 383
Early research (Phase 1)Study completedNCT01497392
What this trial is testing

Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers

Who this might be right for
Adenocarcinoma of the PancreasStage III Pancreatic CancerStage IV Pancreatic Cancer+1 more
Roswell Park Cancer Institute 26
Testing effectiveness (Phase 2)Study completedNCT00191139
What this trial is testing

Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Eli Lilly and Company 64
Large-scale testing (Phase 3)Study completedNCT01193257
What this trial is testing

Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 1,099
Testing effectiveness (Phase 2)Study completedNCT01750281
What this trial is testing

Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.

Who this might be right for
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
AstraZeneca 212
Testing effectiveness (Phase 2)Ended earlyNCT00089544
What this trial is testing

Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall

Who this might be right for
Recurrent Adult Soft Tissue SarcomaStage I Adult Soft Tissue Sarcoma AJCC v7Stage II Adult Soft Tissue Sarcoma AJCC v7+1 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Study completedNCT00005861
What this trial is testing

Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group
Next Page